Diasorin to acquire Luminex for USD 37.00 per share or approximately USD 1.8 billion
Provides access to proven Luminex multiplexing technology and molecular testing solutions to be used in unique testing…
thematics
#Microfluidics
Show filters
Markets
#Compound Semiconductors And Emerging Substrates #Imaging #Memory #Microfluidics #Packaging #Photonics #Power Electronics #RF Devices And Technology #Semiconductor Manufacturing #Sensing
Italy vetoes takeover of semiconductor firm by Chinese company Shenzhen
Fluxergy nabs CE-IVD mark for SARS-CoV-2 POC PCR test
QuantuMDx completes £11m funding round
BioFire Dx receives first FDA marketing clearance for SARS-CoV-2 respiratory panel
Inflammatix secures $102 million in series D financing led by D1 capital partners to commercialize novel host response diagnostics
Roche signs definitive merger agreement with GenMark Diagnostics, to access novel technology to test for broad range of pathogens with one patient sample
